Global Vaccine Contract Manufacturing Market size is expected to reach USD 4.0 billion by 2025, A vaccine provides active acquired immunity to a disease. The demand for vaccine contract manufacturing is increasing in the market. Vaccine manufacturing is a complex process, in which effectivity, safety and consistency are the most important part for the manufacturers. It offers many services such as production process, cell line development, construction & operation of manufacturing product, process optimization, fermentation and analytical characterization, which fuels the market growth in the coming years. The vaccine contract manufacturing market registering a CAGR of 9.3% in the upcoming period as the scope, product types, and its applications are increasing across the globe.
Vaccine contract services offer cost-saving benefits to their clients. Also, they help to save time in operations & management of a research and production facility. The growing demand for vaccine development from the private sector as well as governments in developing and industrialized countries is expected to witness significant growth of the market in the coming years.
Download Free Sample Report @ https://www.millioninsights.com/industry-reports/vaccine-contract-manufacturing-market/request-sample
In the market, various types of vaccines are available such as inactivated vaccines, attenuated vaccines, toxoid-based vaccines, subunit-based vaccines, DNA-based vaccines, recombinant vector vaccines, synthetic vaccines and others. The “attenuated vaccines” is expected to hold the large market share in the upcoming period due to their ability to elicit strong and antibody responses. These vaccines offer lifetime immunities with just one or two doses. Moreover, proper handling conditions, especially with respect to storage and maintenance will continue to drive the segment in the coming years.
In addition, in the market some single as well as combination vaccine are available. The single vaccine such as influenza virus, ebola virus, chickenpox, smallpox, polio, tetanus, tuberculosis and others could be explored in vaccine contract manufacturing industry. The factors that play an important role in the growth of market include increasing demand, growing population, increasing urbanization & industrialization, growing pharmaceutical industry, increase in the number of countries demanding the introduction of vaccines, stringent government rules & regulations and increasing awareness about vaccination & its benefits in developing countries. Moreover, increasing prevalence of various bacterial and viral infections is a main factor drive the growth of the vaccine contract manufacturing market in the next couple of years.
However, high cost of vaccination, regulatory challenges and patent expiration in recent times are negatively impacting the growth of vaccine contract manufacturing industry. The market is widely analyzed based on different regional factors such as gross domestic product (GDP), demographics, acceptance, inflation rate and others. The market is categorized based on vaccine type, product type, workflow, application and geography.
The market is classified into workflow such as downstream and upstream. The “downstream” segment is further segregated into fill & finish operations, packaging and analytical & QC studies whereas the segment “upstream” is segmented into mammalian expression systems, yeast expression systems, bacterial expression systems, baculovirus/insect expression systems and others. Vaccine production requires skilled personnel for downstream as well as upstream processing. The “downstream” segment is expected to witness significant growth in the coming years owing to the robust demand for downstream processing and sophisticated equipment for efficient product recovery.
North America is accounting large market share in the years to come owing to widespread manufacturing of vaccines in this region, coupled with growing presence of large number of biopharmaceutical facilities. State and the other laws pertaining to development of vaccines & other biologics, particularly in Canada and U.S. are expected to boost the market growth in this region. On the other hand, Asia Pacific is projected to grow at a higher CAGR in the next couple of years due to growing population, improving infrastructure in several developing countries, and growing pharmaceutical industry.
The key players contributing to the robust development of the vaccine contract manufacturing market include Lonza, Paragon Bioservices Inc., Ajinomoto Althea Inc., FUJIFILM Diosynth Biotechnologies U.S.A. Inc., Merck KGaA, Cytovance Biologics, Catalent Inc., IDT Biologika GmbH, Albany Molecular Research Inc., PRA Health Sciences, ICON plc., Pharmaceutical Product Development, LLC, and Cobra Bio. The major market players are focusing on inorganic growth to sustain themselves amidst fierce competition. As such, mergers, acquisitions, and joint ventures are the need of the hour.
Market Segment:
Vaccine Contract Manufacturing Vaccine Type Outlook (Revenue, USD Million, 2014 - 2025)
- Attenuated Vaccine
- Inactivated Vaccine
- Subunit Vaccines
- Toxoid Vaccines
- DNA Vaccines
Vaccine Contract Manufacturing Workflow Outlook (Revenue, USD Million, 2014 - 2025)
- Downstream
- Fill & Finish Operations
- Analytical & QC studies
- Packaging
- Upstream
- Mammalian Expression Systems
- Bacterial Expression Systems
- Yeast Expression Systems
- Baculovirus/Insect Expression Systems
- Others
Vaccine Contract Manufacturing Application Outlook (Revenue, USD Million, 2014 - 2025)
- Human Use
- Veterinary
Vaccine Contract Manufacturing Regional Outlook (Revenue, USD Million, 2014 - 2025)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- Asia Pacific
- India
- China
- Latin America
- Brazil
- Middle East & Africa
- South Africa
Browse Full Research Report with TOC @ https://www.millioninsights.com/industry-reports/vaccine-contract-manufacturing-market
Table of content
Chapter 1 Executive Summary
1.1 Market Snapshot
Chapter 2 Research Methodology
2.1 Information Procurement
2.2 Information or Data Analysis
2.3 Market Formulation & Validation
Chapter 3 Vaccine Contract Manufacturing Market Variables, Trends, & Scope
3.1 Market Segmentation & Scope
3.1.1 Market driver analysis
3.1.1.1 Capacity expansion by contract manufacturers for vaccine manufacturing
3.1.1.2 Global increase in vaccination coverage
3.1.1.3 Vaccination innovation and robust vaccine pipeline
3.1.1.4 Cost and time saving benefits offered by contract services
3.1.2 Market Restraint Analysis
3.1.2.1 Limited outsourcing by well-stablished vaccine manufacturers
3.2 Penetration & Growth Prospect Mapping For Diagnostic Assays, 2016
3.3 Vaccine Contract Manufacturing Market-Swot Analysis, By Factor (Political & Legal, Economic, And Technological)
3.4 Industry Analysis - Porter’s
Continued…
Get in Touch
At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions.
Contact Person:
Ryan Manuel
Research Support Specialist, USA
Email: [email protected]
Global Headquarters
Million Insights
Felton Office Plaza 6265 Highway 9 Felton, California 95018, United States
Phone: 1-408-610-2300
Email: [email protected]
Asia Pacific
Million Insights
Office No. 302, 3rd Floor, Manikchand Galleria, Model Colony, Shivaji Nagar, Pune, MH, 411016 India
Phone: 91-20-65300184
Stringent regulatory standards combined with significant fixed costs, and production & development related complications, have partial competition between vaccine producers.
In addition, the trend of subcontracting has developed significantly in the biopharmaceuticals manufacturing.
Factors such as decreased time to market, cost benefits in infrastructure, and operational benefits are the major factors driving the growth of the global vaccine contract manufacturing market.Request COVID Analysis on Vaccine Contract Manufacturing Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19_id=37100 The development of vaccines involves specified resources and supervised technology platforms, which are becoming progressively problematic to start in-house.
On the other hand, emerging and smaller players are subcontracting a comparatively larger share of their scientific and commercial development processes to contract manufacturing partners.
CMOs are increasing their service ranges to deliver end-to-end facilities to sponsors and clients in order to strengthen their existence in the market.
In terms of vaccine type, the market is divided into synthetic vaccines, toxoid vaccines, recombinant vector vaccines, inactivated vaccines, conjugate vaccines, live attenuated vaccines, and subunit vaccines.
It offers many services such as production process, cell line development, construction & operation of manufacturing product, process optimization, fermentation and analytical characterization, which fuels the market growth in the coming years.
Also, they help to save time in operations & management of a research and production facility.
The growing demand for vaccine development from the private sector as well as governments in developing and industrialized countries is expected to witness significant growth of the market in the coming years.In the market, various types of vaccines are available such as inactivated vaccines, attenuated vaccines, toxoid-based vaccines, subunit-based vaccines, DNA-based vaccines, recombinant vector vaccines, synthetic vaccines and others.
The “attenuated vaccines” is expected to hold the large market share in the upcoming period due to their ability to elicit strong and antibody responses.
The single vaccine such as influenza virus, ebola virus, chickenpox, smallpox, polio, tetanus, tuberculosis and others could be explored in vaccine contract manufacturing industry.
The factors that play an important role in the growth of market include increasing demand, growing population, increasing urbanization & industrialization, growing pharmaceutical industry, increase in the number of countries demanding the introduction of vaccines, stringent government rules & regulations and increasing awareness about vaccination & its benefits in developing countries.
Feb 05, 2021: Global Vaccine Contract Manufacturing Market size is expected to reach USD 4.0 billion by 2025, A vaccine provides active acquired immunity to a disease.
It offers many services such as production process, cell line development, construction & operation of manufacturing product, process optimization, fermentation and analytical characterization, which fuels the market growth in the coming years.
Also, they help to save time in operations & management of a research and production facility.
The growing demand for vaccine development from the private sector as well as governments in developing and industrialized countries is expected to witness significant growth of the market in the coming years.Download sample Copy of This Report at: https://www.millioninsights.com/industry-reports/vaccine-contract-manufacturing-market/request-sampleIn the market, various types of vaccines are available such as inactivated vaccines, attenuated vaccines, toxoid-based vaccines, subunit-based vaccines, DNA-based vaccines, recombinant vector vaccines, synthetic vaccines and others.
The “attenuated vaccines” is expected to hold the large market share in the upcoming period due to their ability to elicit strong and antibody responses.
The single vaccine such as influenza virus, ebola virus, chickenpox, smallpox, polio, tetanus, tuberculosis and others could be explored in vaccine contract manufacturing industry.
